Objective: Fewer benefits are obtained from antithrombotic therapy in nonvalvular atrial fibrillation (NVAF) in routine practice than in clinical trials due to inadequate prescribing. This study aimed to assess the adequacy of an... ...

请注册登录后继续浏览